Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 108140 million in 2023. With growing demand in downstream market, the Anti-inflammatory Therapeutics is forecast to a readjusted size of US$ 166150 million by 2030 with a CAGR of 6.3% during review period.
The research report highlights the growth potential of the global Anti-inflammatory Therapeutics market. Anti-inflammatory Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Anti-inflammatory Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Anti-inflammatory Therapeutics market.
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.
Key Features:
The report on Anti-inflammatory Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Anti-inflammatory Therapeutics market. It may include historical data, market segmentation by Type (e.g., Anti-inflammatory Biologics, Non-Steroidal Anti-inflammatory Drugs (NSAIDs)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Anti-inflammatory Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Anti-inflammatory Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Anti-inflammatory Therapeutics industry. This include advancements in Anti-inflammatory Therapeutics technology, Anti-inflammatory Therapeutics new entrants, Anti-inflammatory Therapeutics new investment, and other innovations that are shaping the future of Anti-inflammatory Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Anti-inflammatory Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Anti-inflammatory Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Anti-inflammatory Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Anti-inflammatory Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Anti-inflammatory Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Anti-inflammatory Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Anti-inflammatory Therapeutics market.
Market Segmentation:
Anti-inflammatory Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 108140 million in 2023. With growing demand in downstream market, the Anti-inflammatory Therapeutics is forecast to a readjusted size of US$ 166150 million by 2030 with a CAGR of 6.3% during review period.
The research report highlights the growth potential of the global Anti-inflammatory Therapeutics market. Anti-inflammatory Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Anti-inflammatory Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Anti-inflammatory Therapeutics market.
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.
Key Features:
The report on Anti-inflammatory Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Anti-inflammatory Therapeutics market. It may include historical data, market segmentation by Type (e.g., Anti-inflammatory Biologics, Non-Steroidal Anti-inflammatory Drugs (NSAIDs)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Anti-inflammatory Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Anti-inflammatory Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Anti-inflammatory Therapeutics industry. This include advancements in Anti-inflammatory Therapeutics technology, Anti-inflammatory Therapeutics new entrants, Anti-inflammatory Therapeutics new investment, and other innovations that are shaping the future of Anti-inflammatory Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Anti-inflammatory Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Anti-inflammatory Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Anti-inflammatory Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Anti-inflammatory Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Anti-inflammatory Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Anti-inflammatory Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Anti-inflammatory Therapeutics market.
Market Segmentation:
Anti-inflammatory Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Anti-inflammatory Biologics
- Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
- Corticosteroids
- Others
- Arthritis
- Respiratory Diseases
- Dermatology
- Gastroenterology
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie
- Johnson & Johnson
- Amgen Inc
- AstraZeneca PLC
- Pfizer, Inc
- Novartis
- Roche
- Merck
- Sanofi
- GlaxoSmithKline
- Sun Pharmaceutical Industries Ltd
- TEVA
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-inflammatory Therapeutics Market Size 2019-2030
2.1.2 Anti-inflammatory Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Anti-inflammatory Therapeutics Segment by Type
2.2.1 Anti-inflammatory Biologics
2.2.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
2.2.3 Corticosteroids
2.2.4 Others
2.3 Anti-inflammatory Therapeutics Market Size by Type
2.3.1 Anti-inflammatory Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Anti-inflammatory Therapeutics Segment by Application
2.4.1 Arthritis
2.4.2 Respiratory Diseases
2.4.3 Dermatology
2.4.4 Gastroenterology
2.4.5 Others
2.5 Anti-inflammatory Therapeutics Market Size by Application
2.5.1 Anti-inflammatory Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
3 ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Anti-inflammatory Therapeutics Market Size Market Share by Players
3.1.1 Global Anti-inflammatory Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Anti-inflammatory Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTI-INFLAMMATORY THERAPEUTICS BY REGIONS
4.1 Anti-inflammatory Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Anti-inflammatory Therapeutics Market Size Growth (2019-2024)
4.3 APAC Anti-inflammatory Therapeutics Market Size Growth (2019-2024)
4.4 Europe Anti-inflammatory Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Anti-inflammatory Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Anti-inflammatory Therapeutics Market Size by Country (2019-2024)
5.2 Americas Anti-inflammatory Therapeutics Market Size by Type (2019-2024)
5.3 Americas Anti-inflammatory Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-inflammatory Therapeutics Market Size by Region (2019-2024)
6.2 APAC Anti-inflammatory Therapeutics Market Size by Type (2019-2024)
6.3 APAC Anti-inflammatory Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Anti-inflammatory Therapeutics by Country (2019-2024)
7.2 Europe Anti-inflammatory Therapeutics Market Size by Type (2019-2024)
7.3 Europe Anti-inflammatory Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-inflammatory Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET FORECAST
10.1 Global Anti-inflammatory Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Anti-inflammatory Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Anti-inflammatory Therapeutics Forecast
10.1.3 APAC Anti-inflammatory Therapeutics Forecast
10.1.4 Europe Anti-inflammatory Therapeutics Forecast
10.1.5 Middle East & Africa Anti-inflammatory Therapeutics Forecast
10.2 Americas Anti-inflammatory Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Anti-inflammatory Therapeutics Market Forecast
10.2.2 Canada Anti-inflammatory Therapeutics Market Forecast
10.2.3 Mexico Anti-inflammatory Therapeutics Market Forecast
10.2.4 Brazil Anti-inflammatory Therapeutics Market Forecast
10.3 APAC Anti-inflammatory Therapeutics Forecast by Region (2025-2030)
10.3.1 China Anti-inflammatory Therapeutics Market Forecast
10.3.2 Japan Anti-inflammatory Therapeutics Market Forecast
10.3.3 Korea Anti-inflammatory Therapeutics Market Forecast
10.3.4 Southeast Asia Anti-inflammatory Therapeutics Market Forecast
10.3.5 India Anti-inflammatory Therapeutics Market Forecast
10.3.6 Australia Anti-inflammatory Therapeutics Market Forecast
10.4 Europe Anti-inflammatory Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Anti-inflammatory Therapeutics Market Forecast
10.4.2 France Anti-inflammatory Therapeutics Market Forecast
10.4.3 UK Anti-inflammatory Therapeutics Market Forecast
10.4.4 Italy Anti-inflammatory Therapeutics Market Forecast
10.4.5 Russia Anti-inflammatory Therapeutics Market Forecast
10.5 Middle East & Africa Anti-inflammatory Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Anti-inflammatory Therapeutics Market Forecast
10.5.2 South Africa Anti-inflammatory Therapeutics Market Forecast
10.5.3 Israel Anti-inflammatory Therapeutics Market Forecast
10.5.4 Turkey Anti-inflammatory Therapeutics Market Forecast
10.5.5 GCC Countries Anti-inflammatory Therapeutics Market Forecast
10.6 Global Anti-inflammatory Therapeutics Forecast by Type (2025-2030)
10.7 Global Anti-inflammatory Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Anti-inflammatory Therapeutics Product Offered
11.1.3 AbbVie Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Anti-inflammatory Therapeutics Product Offered
11.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 Amgen Inc
11.3.1 Amgen Inc Company Information
11.3.2 Amgen Inc Anti-inflammatory Therapeutics Product Offered
11.3.3 Amgen Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Amgen Inc Main Business Overview
11.3.5 Amgen Inc Latest Developments
11.4 AstraZeneca PLC
11.4.1 AstraZeneca PLC Company Information
11.4.2 AstraZeneca PLC Anti-inflammatory Therapeutics Product Offered
11.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 AstraZeneca PLC Main Business Overview
11.4.5 AstraZeneca PLC Latest Developments
11.5 Pfizer, Inc
11.5.1 Pfizer, Inc Company Information
11.5.2 Pfizer, Inc Anti-inflammatory Therapeutics Product Offered
11.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Pfizer, Inc Main Business Overview
11.5.5 Pfizer, Inc Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Anti-inflammatory Therapeutics Product Offered
11.6.3 Novartis Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Anti-inflammatory Therapeutics Product Offered
11.7.3 Roche Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 Merck
11.8.1 Merck Company Information
11.8.2 Merck Anti-inflammatory Therapeutics Product Offered
11.8.3 Merck Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Merck Main Business Overview
11.8.5 Merck Latest Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Anti-inflammatory Therapeutics Product Offered
11.9.3 Sanofi Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi Latest Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Information
11.10.2 GlaxoSmithKline Anti-inflammatory Therapeutics Product Offered
11.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 GlaxoSmithKline Main Business Overview
11.10.5 GlaxoSmithKline Latest Developments
11.11 Sun Pharmaceutical Industries Ltd
11.11.1 Sun Pharmaceutical Industries Ltd Company Information
11.11.2 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Offered
11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Sun Pharmaceutical Industries Ltd Main Business Overview
11.11.5 Sun Pharmaceutical Industries Ltd Latest Developments
11.12 TEVA
11.12.1 TEVA Company Information
11.12.2 TEVA Anti-inflammatory Therapeutics Product Offered
11.12.3 TEVA Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 TEVA Main Business Overview
11.12.5 TEVA Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-inflammatory Therapeutics Market Size 2019-2030
2.1.2 Anti-inflammatory Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Anti-inflammatory Therapeutics Segment by Type
2.2.1 Anti-inflammatory Biologics
2.2.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
2.2.3 Corticosteroids
2.2.4 Others
2.3 Anti-inflammatory Therapeutics Market Size by Type
2.3.1 Anti-inflammatory Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Anti-inflammatory Therapeutics Segment by Application
2.4.1 Arthritis
2.4.2 Respiratory Diseases
2.4.3 Dermatology
2.4.4 Gastroenterology
2.4.5 Others
2.5 Anti-inflammatory Therapeutics Market Size by Application
2.5.1 Anti-inflammatory Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
3 ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Anti-inflammatory Therapeutics Market Size Market Share by Players
3.1.1 Global Anti-inflammatory Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Anti-inflammatory Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTI-INFLAMMATORY THERAPEUTICS BY REGIONS
4.1 Anti-inflammatory Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Anti-inflammatory Therapeutics Market Size Growth (2019-2024)
4.3 APAC Anti-inflammatory Therapeutics Market Size Growth (2019-2024)
4.4 Europe Anti-inflammatory Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Anti-inflammatory Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Anti-inflammatory Therapeutics Market Size by Country (2019-2024)
5.2 Americas Anti-inflammatory Therapeutics Market Size by Type (2019-2024)
5.3 Americas Anti-inflammatory Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-inflammatory Therapeutics Market Size by Region (2019-2024)
6.2 APAC Anti-inflammatory Therapeutics Market Size by Type (2019-2024)
6.3 APAC Anti-inflammatory Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Anti-inflammatory Therapeutics by Country (2019-2024)
7.2 Europe Anti-inflammatory Therapeutics Market Size by Type (2019-2024)
7.3 Europe Anti-inflammatory Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-inflammatory Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET FORECAST
10.1 Global Anti-inflammatory Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Anti-inflammatory Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Anti-inflammatory Therapeutics Forecast
10.1.3 APAC Anti-inflammatory Therapeutics Forecast
10.1.4 Europe Anti-inflammatory Therapeutics Forecast
10.1.5 Middle East & Africa Anti-inflammatory Therapeutics Forecast
10.2 Americas Anti-inflammatory Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Anti-inflammatory Therapeutics Market Forecast
10.2.2 Canada Anti-inflammatory Therapeutics Market Forecast
10.2.3 Mexico Anti-inflammatory Therapeutics Market Forecast
10.2.4 Brazil Anti-inflammatory Therapeutics Market Forecast
10.3 APAC Anti-inflammatory Therapeutics Forecast by Region (2025-2030)
10.3.1 China Anti-inflammatory Therapeutics Market Forecast
10.3.2 Japan Anti-inflammatory Therapeutics Market Forecast
10.3.3 Korea Anti-inflammatory Therapeutics Market Forecast
10.3.4 Southeast Asia Anti-inflammatory Therapeutics Market Forecast
10.3.5 India Anti-inflammatory Therapeutics Market Forecast
10.3.6 Australia Anti-inflammatory Therapeutics Market Forecast
10.4 Europe Anti-inflammatory Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Anti-inflammatory Therapeutics Market Forecast
10.4.2 France Anti-inflammatory Therapeutics Market Forecast
10.4.3 UK Anti-inflammatory Therapeutics Market Forecast
10.4.4 Italy Anti-inflammatory Therapeutics Market Forecast
10.4.5 Russia Anti-inflammatory Therapeutics Market Forecast
10.5 Middle East & Africa Anti-inflammatory Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Anti-inflammatory Therapeutics Market Forecast
10.5.2 South Africa Anti-inflammatory Therapeutics Market Forecast
10.5.3 Israel Anti-inflammatory Therapeutics Market Forecast
10.5.4 Turkey Anti-inflammatory Therapeutics Market Forecast
10.5.5 GCC Countries Anti-inflammatory Therapeutics Market Forecast
10.6 Global Anti-inflammatory Therapeutics Forecast by Type (2025-2030)
10.7 Global Anti-inflammatory Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Anti-inflammatory Therapeutics Product Offered
11.1.3 AbbVie Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Anti-inflammatory Therapeutics Product Offered
11.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 Amgen Inc
11.3.1 Amgen Inc Company Information
11.3.2 Amgen Inc Anti-inflammatory Therapeutics Product Offered
11.3.3 Amgen Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Amgen Inc Main Business Overview
11.3.5 Amgen Inc Latest Developments
11.4 AstraZeneca PLC
11.4.1 AstraZeneca PLC Company Information
11.4.2 AstraZeneca PLC Anti-inflammatory Therapeutics Product Offered
11.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 AstraZeneca PLC Main Business Overview
11.4.5 AstraZeneca PLC Latest Developments
11.5 Pfizer, Inc
11.5.1 Pfizer, Inc Company Information
11.5.2 Pfizer, Inc Anti-inflammatory Therapeutics Product Offered
11.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Pfizer, Inc Main Business Overview
11.5.5 Pfizer, Inc Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Anti-inflammatory Therapeutics Product Offered
11.6.3 Novartis Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Anti-inflammatory Therapeutics Product Offered
11.7.3 Roche Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 Merck
11.8.1 Merck Company Information
11.8.2 Merck Anti-inflammatory Therapeutics Product Offered
11.8.3 Merck Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Merck Main Business Overview
11.8.5 Merck Latest Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Anti-inflammatory Therapeutics Product Offered
11.9.3 Sanofi Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi Latest Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Information
11.10.2 GlaxoSmithKline Anti-inflammatory Therapeutics Product Offered
11.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 GlaxoSmithKline Main Business Overview
11.10.5 GlaxoSmithKline Latest Developments
11.11 Sun Pharmaceutical Industries Ltd
11.11.1 Sun Pharmaceutical Industries Ltd Company Information
11.11.2 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Offered
11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Sun Pharmaceutical Industries Ltd Main Business Overview
11.11.5 Sun Pharmaceutical Industries Ltd Latest Developments
11.12 TEVA
11.12.1 TEVA Company Information
11.12.2 TEVA Anti-inflammatory Therapeutics Product Offered
11.12.3 TEVA Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 TEVA Main Business Overview
11.12.5 TEVA Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-inflammatory Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Anti-inflammatory Biologics
Table 3. Major Players of Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Table 4. Major Players of Corticosteroids
Table 5. Major Players of Others
Table 6. Anti-inflammatory Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Anti-inflammatory Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
Table 9. Anti-inflammatory Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Anti-inflammatory Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
Table 12. Global Anti-inflammatory Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Anti-inflammatory Therapeutics Revenue Market Share by Player (2019-2024)
Table 14. Anti-inflammatory Therapeutics Key Players Head office and Products Offered
Table 15. Anti-inflammatory Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Anti-inflammatory Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Anti-inflammatory Therapeutics Market Size Market Share by Regions (2019-2024)
Table 20. Global Anti-inflammatory Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Anti-inflammatory Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Anti-inflammatory Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Anti-inflammatory Therapeutics Market Size Market Share by Country (2019-2024)
Table 24. Americas Anti-inflammatory Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
Table 26. Americas Anti-inflammatory Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
Table 28. APAC Anti-inflammatory Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Anti-inflammatory Therapeutics Market Size Market Share by Region (2019-2024)
Table 30. APAC Anti-inflammatory Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
Table 32. APAC Anti-inflammatory Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
Table 34. Europe Anti-inflammatory Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Anti-inflammatory Therapeutics Market Size Market Share by Country (2019-2024)
Table 36. Europe Anti-inflammatory Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
Table 38. Europe Anti-inflammatory Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Anti-inflammatory Therapeutics
Table 47. Key Market Challenges & Risks of Anti-inflammatory Therapeutics
Table 48. Key Industry Trends of Anti-inflammatory Therapeutics
Table 49. Global Anti-inflammatory Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Anti-inflammatory Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Anti-inflammatory Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Anti-inflammatory Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. AbbVie Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 54. AbbVie Anti-inflammatory Therapeutics Product Offered
Table 55. AbbVie Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. AbbVie Main Business
Table 57. AbbVie Latest Developments
Table 58. Johnson & Johnson Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 59. Johnson & Johnson Anti-inflammatory Therapeutics Product Offered
Table 60. Johnson & Johnson Main Business
Table 61. Johnson & Johnson Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Johnson & Johnson Latest Developments
Table 63. Amgen Inc Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 64. Amgen Inc Anti-inflammatory Therapeutics Product Offered
Table 65. Amgen Inc Main Business
Table 66. Amgen Inc Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Amgen Inc Latest Developments
Table 68. AstraZeneca PLC Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 69. AstraZeneca PLC Anti-inflammatory Therapeutics Product Offered
Table 70. AstraZeneca PLC Main Business
Table 71. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. AstraZeneca PLC Latest Developments
Table 73. Pfizer, Inc Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 74. Pfizer, Inc Anti-inflammatory Therapeutics Product Offered
Table 75. Pfizer, Inc Main Business
Table 76. Pfizer, Inc Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Pfizer, Inc Latest Developments
Table 78. Novartis Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 79. Novartis Anti-inflammatory Therapeutics Product Offered
Table 80. Novartis Main Business
Table 81. Novartis Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Novartis Latest Developments
Table 83. Roche Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 84. Roche Anti-inflammatory Therapeutics Product Offered
Table 85. Roche Main Business
Table 86. Roche Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Roche Latest Developments
Table 88. Merck Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 89. Merck Anti-inflammatory Therapeutics Product Offered
Table 90. Merck Main Business
Table 91. Merck Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Merck Latest Developments
Table 93. Sanofi Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 94. Sanofi Anti-inflammatory Therapeutics Product Offered
Table 95. Sanofi Main Business
Table 96. Sanofi Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Sanofi Latest Developments
Table 98. GlaxoSmithKline Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 99. GlaxoSmithKline Anti-inflammatory Therapeutics Product Offered
Table 100. GlaxoSmithKline Main Business
Table 101. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. GlaxoSmithKline Latest Developments
Table 103. Sun Pharmaceutical Industries Ltd Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 104. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Offered
Table 105. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Sun Pharmaceutical Industries Ltd Main Business
Table 107. Sun Pharmaceutical Industries Ltd Latest Developments
Table 108. TEVA Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 109. TEVA Anti-inflammatory Therapeutics Product Offered
Table 110. TEVA Main Business
Table 111. TEVA Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. TEVA Latest Developments
Table 1. Anti-inflammatory Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Anti-inflammatory Biologics
Table 3. Major Players of Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Table 4. Major Players of Corticosteroids
Table 5. Major Players of Others
Table 6. Anti-inflammatory Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Anti-inflammatory Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
Table 9. Anti-inflammatory Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Anti-inflammatory Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
Table 12. Global Anti-inflammatory Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Anti-inflammatory Therapeutics Revenue Market Share by Player (2019-2024)
Table 14. Anti-inflammatory Therapeutics Key Players Head office and Products Offered
Table 15. Anti-inflammatory Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Anti-inflammatory Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Anti-inflammatory Therapeutics Market Size Market Share by Regions (2019-2024)
Table 20. Global Anti-inflammatory Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Anti-inflammatory Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Anti-inflammatory Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Anti-inflammatory Therapeutics Market Size Market Share by Country (2019-2024)
Table 24. Americas Anti-inflammatory Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
Table 26. Americas Anti-inflammatory Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
Table 28. APAC Anti-inflammatory Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Anti-inflammatory Therapeutics Market Size Market Share by Region (2019-2024)
Table 30. APAC Anti-inflammatory Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
Table 32. APAC Anti-inflammatory Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
Table 34. Europe Anti-inflammatory Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Anti-inflammatory Therapeutics Market Size Market Share by Country (2019-2024)
Table 36. Europe Anti-inflammatory Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
Table 38. Europe Anti-inflammatory Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Anti-inflammatory Therapeutics
Table 47. Key Market Challenges & Risks of Anti-inflammatory Therapeutics
Table 48. Key Industry Trends of Anti-inflammatory Therapeutics
Table 49. Global Anti-inflammatory Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Anti-inflammatory Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Anti-inflammatory Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Anti-inflammatory Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. AbbVie Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 54. AbbVie Anti-inflammatory Therapeutics Product Offered
Table 55. AbbVie Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. AbbVie Main Business
Table 57. AbbVie Latest Developments
Table 58. Johnson & Johnson Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 59. Johnson & Johnson Anti-inflammatory Therapeutics Product Offered
Table 60. Johnson & Johnson Main Business
Table 61. Johnson & Johnson Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Johnson & Johnson Latest Developments
Table 63. Amgen Inc Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 64. Amgen Inc Anti-inflammatory Therapeutics Product Offered
Table 65. Amgen Inc Main Business
Table 66. Amgen Inc Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Amgen Inc Latest Developments
Table 68. AstraZeneca PLC Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 69. AstraZeneca PLC Anti-inflammatory Therapeutics Product Offered
Table 70. AstraZeneca PLC Main Business
Table 71. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. AstraZeneca PLC Latest Developments
Table 73. Pfizer, Inc Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 74. Pfizer, Inc Anti-inflammatory Therapeutics Product Offered
Table 75. Pfizer, Inc Main Business
Table 76. Pfizer, Inc Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Pfizer, Inc Latest Developments
Table 78. Novartis Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 79. Novartis Anti-inflammatory Therapeutics Product Offered
Table 80. Novartis Main Business
Table 81. Novartis Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Novartis Latest Developments
Table 83. Roche Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 84. Roche Anti-inflammatory Therapeutics Product Offered
Table 85. Roche Main Business
Table 86. Roche Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Roche Latest Developments
Table 88. Merck Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 89. Merck Anti-inflammatory Therapeutics Product Offered
Table 90. Merck Main Business
Table 91. Merck Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Merck Latest Developments
Table 93. Sanofi Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 94. Sanofi Anti-inflammatory Therapeutics Product Offered
Table 95. Sanofi Main Business
Table 96. Sanofi Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Sanofi Latest Developments
Table 98. GlaxoSmithKline Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 99. GlaxoSmithKline Anti-inflammatory Therapeutics Product Offered
Table 100. GlaxoSmithKline Main Business
Table 101. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. GlaxoSmithKline Latest Developments
Table 103. Sun Pharmaceutical Industries Ltd Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 104. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Offered
Table 105. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Sun Pharmaceutical Industries Ltd Main Business
Table 107. Sun Pharmaceutical Industries Ltd Latest Developments
Table 108. TEVA Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 109. TEVA Anti-inflammatory Therapeutics Product Offered
Table 110. TEVA Main Business
Table 111. TEVA Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. TEVA Latest Developments
LIST OF FIGURES
Figure 1. Anti-inflammatory Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-inflammatory Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Anti-inflammatory Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Anti-inflammatory Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Anti-inflammatory Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Anti-inflammatory Therapeutics Market Size Market Share by Type in 2023
Figure 10. Anti-inflammatory Therapeutics in Arthritis
Figure 11. Global Anti-inflammatory Therapeutics Market: Arthritis (2019-2024) & ($ Millions)
Figure 12. Anti-inflammatory Therapeutics in Respiratory Diseases
Figure 13. Global Anti-inflammatory Therapeutics Market: Respiratory Diseases (2019-2024) & ($ Millions)
Figure 14. Anti-inflammatory Therapeutics in Dermatology
Figure 15. Global Anti-inflammatory Therapeutics Market: Dermatology (2019-2024) & ($ Millions)
Figure 16. Anti-inflammatory Therapeutics in Gastroenterology
Figure 17. Global Anti-inflammatory Therapeutics Market: Gastroenterology (2019-2024) & ($ Millions)
Figure 18. Anti-inflammatory Therapeutics in Others
Figure 19. Global Anti-inflammatory Therapeutics Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Anti-inflammatory Therapeutics Market Size Market Share by Application in 2023
Figure 21. Global Anti-inflammatory Therapeutics Revenue Market Share by Player in 2023
Figure 22. Global Anti-inflammatory Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Anti-inflammatory Therapeutics Market Size 2019-2024 ($ Millions)
Figure 24. APAC Anti-inflammatory Therapeutics Market Size 2019-2024 ($ Millions)
Figure 25. Europe Anti-inflammatory Therapeutics Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Anti-inflammatory Therapeutics Market Size 2019-2024 ($ Millions)
Figure 27. Americas Anti-inflammatory Therapeutics Value Market Share by Country in 2023
Figure 28. United States Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Anti-inflammatory Therapeutics Market Size Market Share by Region in 2023
Figure 33. APAC Anti-inflammatory Therapeutics Market Size Market Share by Type in 2023
Figure 34. APAC Anti-inflammatory Therapeutics Market Size Market Share by Application in 2023
Figure 35. China Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Anti-inflammatory Therapeutics Market Size Market Share by Country in 2023
Figure 42. Europe Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
Figure 43. Europe Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
Figure 44. Germany Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. APAC Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Europe Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. United States Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Canada Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. China Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Japan Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Korea Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. India Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Australia Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Germany Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. France Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. UK Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Italy Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Russia Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Spain Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 79. Israel Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 82. Global Anti-inflammatory Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Anti-inflammatory Therapeutics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Anti-inflammatory Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-inflammatory Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Anti-inflammatory Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Anti-inflammatory Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Anti-inflammatory Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Anti-inflammatory Therapeutics Market Size Market Share by Type in 2023
Figure 10. Anti-inflammatory Therapeutics in Arthritis
Figure 11. Global Anti-inflammatory Therapeutics Market: Arthritis (2019-2024) & ($ Millions)
Figure 12. Anti-inflammatory Therapeutics in Respiratory Diseases
Figure 13. Global Anti-inflammatory Therapeutics Market: Respiratory Diseases (2019-2024) & ($ Millions)
Figure 14. Anti-inflammatory Therapeutics in Dermatology
Figure 15. Global Anti-inflammatory Therapeutics Market: Dermatology (2019-2024) & ($ Millions)
Figure 16. Anti-inflammatory Therapeutics in Gastroenterology
Figure 17. Global Anti-inflammatory Therapeutics Market: Gastroenterology (2019-2024) & ($ Millions)
Figure 18. Anti-inflammatory Therapeutics in Others
Figure 19. Global Anti-inflammatory Therapeutics Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Anti-inflammatory Therapeutics Market Size Market Share by Application in 2023
Figure 21. Global Anti-inflammatory Therapeutics Revenue Market Share by Player in 2023
Figure 22. Global Anti-inflammatory Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Anti-inflammatory Therapeutics Market Size 2019-2024 ($ Millions)
Figure 24. APAC Anti-inflammatory Therapeutics Market Size 2019-2024 ($ Millions)
Figure 25. Europe Anti-inflammatory Therapeutics Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Anti-inflammatory Therapeutics Market Size 2019-2024 ($ Millions)
Figure 27. Americas Anti-inflammatory Therapeutics Value Market Share by Country in 2023
Figure 28. United States Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Anti-inflammatory Therapeutics Market Size Market Share by Region in 2023
Figure 33. APAC Anti-inflammatory Therapeutics Market Size Market Share by Type in 2023
Figure 34. APAC Anti-inflammatory Therapeutics Market Size Market Share by Application in 2023
Figure 35. China Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Anti-inflammatory Therapeutics Market Size Market Share by Country in 2023
Figure 42. Europe Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
Figure 43. Europe Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
Figure 44. Germany Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Anti-inflammatory Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. APAC Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Europe Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. United States Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Canada Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. China Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Japan Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Korea Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. India Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Australia Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Germany Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. France Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. UK Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Italy Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Russia Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Spain Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 79. Israel Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Anti-inflammatory Therapeutics Market Size 2025-2030 ($ Millions)
Figure 82. Global Anti-inflammatory Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Anti-inflammatory Therapeutics Market Size Market Share Forecast by Application (2025-2030)
